Pomanda estimates the enterprise value of C & P APOTHECARIES LIMITED at £1.8m based on a Turnover of £5.2m and 0.35x industry multiple (adjusted for size and gross margin).
c & p apothecaries limitedEstimated Valuation
£4m
Pomanda estimates the enterprise value of C & P APOTHECARIES LIMITED at £4m based on an EBITDA of £1m and a 3.89x industry multiple (adjusted for size and gross margin).
c & p apothecaries limitedEstimated Valuation
£3m
Pomanda estimates the enterprise value of C & P APOTHECARIES LIMITED at £3m based on Net Assets of £1.5m and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
C & P Apothecaries LimitedOverview
C & P Apothecaries Limited is a live company located in merseyside, L1 9ER with a Companies House number of 05238287. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in September 2004, it's largest shareholder is
patrick higgins
with a 59% stake. C & P Apothecaries Limited is a mature,
mid sized company, Pomanda has estimated its turnover at
£5.2m with
healthy
growth in recent years.
Pomanda's financial health check has awarded C & P Apothecaries Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
3 Strong
2 Regular
6 Weak
Size
annual sales of £5.2m, make it smaller than the average company (£12.6m)
£5.2m - C & P Apothecaries Limited
£12.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (7.7%)
6% - C & P Apothecaries Limited
7.7% - Industry AVG
Production
with a gross margin of 27.2%, this company has a comparable cost of product (32.1%)
27.2% - C & P Apothecaries Limited
32.1% - Industry AVG
Profitability
an operating margin of 19.2% make it more profitable than the average company (2.6%)
19.2% - C & P Apothecaries Limited
2.6% - Industry AVG
Employees
with 15 employees, this is below the industry average (72)
15 - C & P Apothecaries Limited
72 - Industry AVG
Pay Structure
on an average salary of £26.8k, the company has an equivalent pay structure (£26.8k)
£26.8k - C & P Apothecaries Limited
£26.8k - Industry AVG
Efficiency
resulting in sales per employee of £346.8k, this is more efficient (£145k)
£346.8k - C & P Apothecaries Limited
£145k - Industry AVG
Debtor Days
it gets paid by customers after 89 days, this is later than average (30 days)
89 days - C & P Apothecaries Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is quicker than average (65 days)
17 days - C & P Apothecaries Limited
65 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - C & P Apothecaries Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (13 weeks)
0 weeks - C & P Apothecaries Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 10.9%, this is a lower level of debt than the average (59.7%)
10.9% - C & P Apothecaries Limited
59.7% - Industry AVG
C & P APOTHECARIES LIMITED financials
EXPORT
C & P Apothecaries Limited's latest turnover from February 2024 is estimated at £5.2 million and the company has net assets of £1.5 million. According to their latest financial statements, C & P Apothecaries Limited has 15 employees and maintains cash reserves of £2.1 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Feb 2024
Feb 2023
Feb 2022
Feb 2021
Feb 2020
Feb 2019
Feb 2018
Feb 2017
Feb 2016
Feb 2015
Feb 2014
Feb 2013
Feb 2012
Feb 2011
Feb 2010
Turnover
5,202,020
2,063,547
3,845,798
4,376,999
4,370,199
4,345,018
3,900,463
4,144,606
3,803,674
3,689,761
3,606,777
5,592,168
2,251,290
3,261,222
3,559,880
Other Income Or Grants
Cost Of Sales
3,789,595
1,471,893
2,754,582
3,239,559
3,230,544
3,158,099
2,778,890
2,959,195
2,783,450
2,693,378
2,592,453
4,070,067
1,668,658
2,424,853
2,474,678
Gross Profit
1,412,425
591,654
1,091,216
1,137,441
1,139,655
1,186,919
1,121,573
1,185,411
1,020,224
996,383
1,014,324
1,522,102
582,633
836,370
1,085,202
Admin Expenses
413,832
877,962
590,211
807,403
739,117
1,334,027
1,186,228
1,280,636
1,198,650
902,769
752,135
1,059,955
863,435
421,883
951,301
Operating Profit
998,593
-286,308
501,005
330,038
400,538
-147,108
-64,655
-95,225
-178,426
93,614
262,189
462,147
-280,802
414,487
133,901
Interest Payable
111,270
197,720
181,675
43,482
Interest Receivable
2,773
8,500
2,144
357
1,551
1,848
1,270
679
1,533
1,146
350
15
33
388
Pre-Tax Profit
1,001,367
-277,808
503,149
330,395
402,089
-145,260
-63,385
-94,546
-176,893
94,759
262,539
350,892
-478,489
233,200
90,419
Tax
-250,342
-95,598
-62,775
-76,397
-19,899
-60,384
-84,214
-65,296
-27,334
Profit After Tax
751,025
-277,808
407,551
267,620
325,692
-145,260
-63,385
-94,546
-176,893
74,860
202,155
266,678
-478,489
167,904
63,085
Dividends Paid
Retained Profit
751,025
-277,808
407,551
267,620
325,692
-145,260
-63,385
-94,546
-176,893
74,860
202,155
266,678
-478,489
167,904
63,085
Employee Costs
402,321
328,151
390,867
552,668
648,378
725,940
887,355
851,732
412,585
429,143
423,001
616,531
251,238
354,066
372,456
Number Of Employees
15
13
17
26
31
35
45
46
24
25
25
37
15
21
23
EBITDA*
1,023,899
-235,806
576,203
468,541
562,547
28,166
114,973
86,786
-6,010
262,321
426,407
462,147
-158,468
574,332
269,166
* Earnings Before Interest, Tax, Depreciation and Amortisation
Feb 2024
Feb 2023
Feb 2022
Feb 2021
Feb 2020
Feb 2019
Feb 2018
Feb 2017
Feb 2016
Feb 2015
Feb 2014
Feb 2013
Feb 2012
Feb 2011
Feb 2010
Tangible Assets
178,160
259,073
280,129
320,873
377,863
561,844
604,893
663,217
1,010,390
1,530,813
1,496,131
1,539,496
1,558,789
1,602,319
1,614,132
Intangible Assets
87,168
108,005
444,379
1,028,090
1,171,160
1,292,464
1,413,768
1,531,408
1,646,838
1,767,692
1,888,545
1,152,317
1,230,317
1,308,317
Investments & Other
245,102
245,100
245,100
245,100
387,720
387,720
387,720
387,720
1,400,000
Debtors (Due After 1 year)
103,400
Total Fixed Assets
423,262
591,341
633,234
1,010,352
1,793,673
2,120,724
2,285,077
2,464,705
2,541,798
3,177,651
3,263,823
3,428,041
4,214,506
2,832,636
2,922,449
Stock & work in progress
113,968
100,537
133,958
216,618
234,380
256,732
262,710
233,507
210,371
188,619
171,906
146,646
185,033
191,246
Trade Debtors
1,279,480
440,733
1,158,017
1,342,951
1,096,978
989,720
819,480
869,062
807,021
552,696
623,822
1,211,781
511,643
805,872
703,789
Group Debtors
Misc Debtors
98,341
Cash
2,079
103,577
321,441
536,232
176,934
236,637
256,185
251,751
291,329
321,973
136,386
3,599
2,499
10,641
144,416
misc current assets
total current assets
1,281,559
658,278
1,579,995
2,013,141
1,490,530
1,460,737
1,332,397
1,383,523
1,331,857
1,085,040
948,827
1,387,286
660,788
1,001,546
1,137,792
total assets
1,704,821
1,249,619
2,213,229
3,023,493
3,284,203
3,581,461
3,617,474
3,848,228
3,873,655
4,262,691
4,212,650
4,815,327
4,875,294
3,834,182
4,060,241
Bank overdraft
488,689
270,000
270,000
Bank loan
Trade Creditors
184,958
468,792
1,153,979
1,170,267
1,450,009
1,490,112
1,237,263
1,237,129
1,055,704
1,718,001
1,445,836
1,903,269
611,225
603,949
672,363
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
50,545
total current liabilities
184,958
468,792
1,153,979
1,170,267
1,450,009
1,490,112
1,237,263
1,237,129
1,055,704
1,718,001
1,445,836
1,903,269
1,099,914
873,949
992,908
loans
2,935,000
2,390,000
2,660,000
hp & lease commitments
Accruals and Deferred Income
other liabilities
1,198,497
1,345,484
1,927,093
2,068,651
2,226,497
2,353,339
1,899,449
2,208,700
2,553,636
748,636
provisions
11,989
12,604
15,634
21,065
22,303
24,347
34,004
19,468
23,204
10,937
13,400
13,400
13,400
18,404
total long term liabilities
11,989
12,604
1,214,131
1,366,549
1,949,396
2,092,998
2,260,501
2,372,807
1,922,653
2,219,637
2,567,036
3,697,036
2,403,400
2,678,404
total liabilities
184,958
480,781
1,166,583
2,384,398
2,816,558
3,439,508
3,330,261
3,497,630
3,428,511
3,640,654
3,665,473
4,470,305
4,796,950
3,277,349
3,671,312
net assets
1,519,863
768,838
1,046,646
639,095
467,645
141,953
287,213
350,598
445,144
622,037
547,177
345,022
78,344
556,833
388,929
total shareholders funds
1,519,863
768,838
1,046,646
639,095
467,645
141,953
287,213
350,598
445,144
622,037
547,177
345,022
78,344
556,833
388,929
Feb 2024
Feb 2023
Feb 2022
Feb 2021
Feb 2020
Feb 2019
Feb 2018
Feb 2017
Feb 2016
Feb 2015
Feb 2014
Feb 2013
Feb 2012
Feb 2011
Feb 2010
Operating Activities
Operating Profit
998,593
-286,308
501,005
330,038
400,538
-147,108
-64,655
-95,225
-178,426
93,614
262,189
462,147
-280,802
414,487
133,901
Depreciation
25,306
29,665
30,244
36,912
40,705
53,970
58,324
60,705
51,564
47,853
43,365
44,334
81,845
59,935
Amortisation
20,837
44,954
101,591
121,304
121,304
121,304
121,306
120,852
120,854
120,853
78,000
78,000
75,330
Tax
-250,342
-95,598
-62,775
-76,397
-19,899
-60,384
-84,214
-65,296
-27,334
Stock
-113,968
13,431
-33,421
-82,660
-17,762
-22,352
-5,978
29,203
23,136
21,752
16,713
25,260
-38,387
-6,213
191,246
Debtors
838,747
-717,284
-184,934
245,973
107,258
170,240
-49,582
62,041
254,325
-71,126
-587,959
596,738
-190,829
3,742
802,130
Creditors
-283,834
-685,187
-16,288
-279,742
-40,103
252,849
134
181,425
-662,297
272,165
-457,433
1,292,044
7,276
-68,414
672,363
Accruals and Deferred Income
-50,545
50,545
Deferred Taxes & Provisions
-11,989
-615
-3,030
-5,431
-1,238
-2,044
-9,657
14,536
-3,736
12,267
-2,463
-5,004
18,404
Cash flow from operations
-247,045
-217,755
679,642
-42,720
355,313
131,083
161,010
191,503
-949,504
576,228
477,373
1,047,979
78,024
387,544
-10,232
Investing Activities
capital expenditure
142,775
-8,609
301,920
502,198
165,042
-10,921
282,802
463,437
-82,535
-716,935
-804
-70,032
-3,057,714
Change in Investments
2
-142,620
387,720
-1,400,000
1,400,000
cash flow from investments
142,773
-8,609
301,920
644,818
165,042
-10,921
-104,918
463,437
-82,535
683,065
-1,400,804
-70,032
-3,057,714
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
-2,935,000
545,000
-270,000
2,660,000
Hire Purchase and Lease Commitments
other long term liabilities
-1,198,497
-146,987
-581,609
-141,558
-157,846
-126,842
453,890
-309,251
-344,936
1,805,000
748,636
share issue
-96,170
325,844
interest
2,773
8,500
2,144
357
1,551
1,848
1,270
679
1,533
1,146
350
-111,255
-197,687
-181,287
-43,482
cash flow from financing
2,773
8,500
-1,196,353
-242,800
-580,058
-139,710
-156,576
-126,163
455,423
-308,105
-344,586
-1,241,255
1,095,949
-451,287
2,942,362
cash and cash equivalents
cash
-101,498
-217,864
-214,791
359,298
-59,703
-19,548
4,434
-39,578
-30,644
185,587
132,787
1,100
-8,142
-133,775
144,416
overdraft
-488,689
218,689
270,000
change in cash
-101,498
-217,864
-214,791
359,298
-59,703
-19,548
4,434
-39,578
-30,644
185,587
132,787
489,789
-226,831
-133,775
-125,584
c & p apothecaries limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for c & p apothecaries limited. Get real-time insights into c & p apothecaries limited's credit score, group structure and payment trends.
Perform a competitor analysis for c & p apothecaries limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in L 1 area or any other competitors across 12 key performance metrics.
c & p apothecaries limited Ownership
C & P APOTHECARIES LIMITED group structure
C & P Apothecaries Limited has 3 subsidiary companies.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 28 charges/mortgages relating to c & p apothecaries limited. Currently there are 0 open charges and 28 have been satisfied in the past.
c & p apothecaries limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for C & P APOTHECARIES LIMITED. This can take several minutes, an email will notify you when this has completed.
c & p apothecaries limitedCompanies House Filings - See Documents
